NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells

The PI3K/Akt/mTOR pathway is a prototypic survival pathway and constitutively activated in many malignant conditions. Moreover, activation of the PI3K/Akt/mTOR pathway confers resistance to various cancer therapies and is often associated with a poor prognosis. In this study, we explored the antitum...

Descripción completa

Detalles Bibliográficos
Autores principales: MOON, DU G., LEE, SANG E., OH, MI M., LEE, SANG C., JEONG, SEONG J., HONG, SUNG K., YOON, CHEOL Y., BYUN, SEOK S., PARK, HONG S., CHEON, JUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121414/
https://www.ncbi.nlm.nih.gov/pubmed/24969552
http://dx.doi.org/10.3892/ijo.2014.2505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121414/
https://www.ncbi.nlm.nih.gov/pubmed/24969552
http://dx.doi.org/10.3892/ijo.2014.2505

Ejemplares similares